Persistent expression of Ia antigen and viral genome in visna-maedi virus-induced inflammatory cells. Possible role of lentivirus-induced interferon by unknown
PERSISTENT  EXPRESSION  OF  Ia  ANTIGEN  AND  VIRAL 
GENOME  IN  VISNA-MAEDI  VIRUS-INDUCED 
INFLAMMATORY  CELLS 
Possible Role of Lentivirus-induced  Interferon 
BY  PETER  G.  E.  KENNEDY,*  OPENDRA  NARAYAN,**  ZAHRA  GHOTBI,* 
JOHN  HOPKINS, Ih  HOWARD  E.  GENDELMAN,*  AND JANICE  E.  CLEMENTS *§ 
From the Departments  of *Neurology, *Comparative Medicine, §Molecular Genetics, The Johns 
Hopkins University School of Medicine, Baltimore, Maryland 21205; and the m  Department  of 
Veterinary Pathology, Royal Dick School of Veterinary Studies, Edinburgh, United Kingdom 
Visna and maedi of sheep are classical "slow" virus diseases that  have a  long 
incubation period and progressive debilitating clinical courses (1). Histologically, 
lesions are characterized by infiltration and proliferation of mononuclear cells in 
an  active-chronic  inflammatory  process  in  specific  organ  systems  such  as  the 
brain, lung, joints, and mammary gland (2). The etiological agents of the disease 
complex belong to a newly recognized taxonomic group called lentiviruses, which 
are  nononcogenic,  replication-competent  retroviruses  (1).  The  viruses  cause 
persistent  infections  in  their  natural  hosts  and  replicate  at  a  restrictive  level 
indefinitely  (3,  4).  In  nonneural  tissues  such  as  the  lung,  chronic  progressive 
lesions develop, whereas the lesions in the central nervous system (CNS) l appear 
to  represent  an  episodic  pathogenesis  with  repeated  episodes of acute  lesions 
leading to repair (5). 
Studies  on  host-virus  interactions  in  vivo  (6)  have  shown  that  cells  of the 
macrophage lineage are the main virus host cells but that replication is confined 
to macrophages only in those tissues which develop inflammatory lesions. Thus, 
the minimally productive virus replication  in specific populations of tissue mac- 
rophages forms the basis of persistent infection of the animal, "slow" or restricted 
virus  replication  in  tissue,  and  lymphoproliferative  pathologic  responses  that 
occur at  the  sites  of virus  replication.  The  mechanisms  of the  lesions  remain 
unknown.  The recent discovery (preceding article  [7]) that an interferon  (IFN) 
is induced during interaction  between lymphocytes and lentivirus-infected mac- 
rophages  provides  a  potentially  important  bridge  linking  the  virus-infected 
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macrophage and the lymphoproliferative host response. Since one of the immu- 
nological effects of IFN (gamma) is the induction of expression of Ia antigens in 
macrophages (8,  9), thus causing enhancement of antigen processing and pres- 
entation by macrophages (10), we hypothesize that, in the chronic-active visna- 
maedi virus-induced lesion,  IFN  induced by the inflammatory cells may cause 
increased expression of Ia antigens in macrophages. We show in this report that 
Ia antigens  are  expressed continuously and at  high  levels in  macrophages-like 
cells in the inflammatory lesions. We show further that, in interactions between 
the lentivirus-induced IFN (LV-IFN) and cultured sheep macrophages, the LV- 
IFN causes expression of Ia antigen in the macropbages, and that persistence of 
expression  requires  the  continuous  presence  of  LV-IFN  in  the  medium.  In 
addition, the IFN restricted LV replication in cultured macrophages. We suggest 
that such an IFN, produced in vivo, may play an important role in causing the 
lymphoproliferative response  through  its effects on macrophage  Ia  expression 
and may curtail virus replication in the macrophages, providing the net effect of 
"slow replication." 
Materials and Methods 
Virus.  Lentivirus VMA-5 was used in all the experiments in this study. This virus is a 
field strain of visna virus isolated in Idaho from a sheep with typical inflammatory lesions 
in the lungs, joints, and brain. VMA-5 virus was cultivated in a cell line of sheep alveolar 
macrophages transformed by SV40 (11). These cells retain histochemical, functional, and 
antigenic characteristics of the normal parental alveolar macrophages (11).  The titer of 
supernatant fluids from infected cultures was 5 x  105 infectious doses (TCIDs0)/mi. 
Sheep.  Two 3-mo-old Corriedale lambs were anesthetized with halothane, and virus 
was inoculated once into both the right and left cerebral hemispheres and also deposited 
in the right anterior lobe of the lung using fiberoptic endoscopy. The animals were killed 
at 2 wk and 12 wk after inoculation, and perfused through the heart first with phosphate- 
buffered saline  (PBS)  and then  with  periodate-lysine-paraformaldehyde-glutaraldehyde 
(PLPG) (12) as previously described (6). Small portions of various tissues were post-fixed 
in PLPG, washed in PBS, embedded in paraffin, which was then serial section cut and 
heat-baked onto glass slides pretreated with poly-D-lysine.  Slides were then processed as 
described below. Brain tissues from both animals were studied, but all other tissues used 
in this study were obtained from the sheep killed at 12 wk. 
lmmunocytochemistry.  The antibodies used in this study were a rat monoclonal antibody 
to sheep Ia antigen (13), and a rabbit polyvalent antiserum to sheep alveolar macrophages, 
of known specificities (11). This antiserum reacts with monocytes and selected macrophage 
populations  in  sections of a  variety of fixed normal  sheep  tissues.  Tissue sections or 
cytocentrifuged cell preparations (see below) were studied using the avidin-biotin-coupled 
peroxidase complex (12). Tissues or cytospun cell preparations were reacted sequentially 
with each of the following reagents (a) 2% normal rabbit serum for 20 min; (b) monoclonal 
rat antibody to sheep Ia antigen or rabbit polyvalent antiserum to sheep macrophages, 
for 30 min; (c) biotinylated antibody to rat or rabbit immunoglobulins (Vector Labora- 
tories, Inc., Burlingame, CA) diluted 1:100, for 30 min; (d) 0.1% hydrogen peroxide in 
methanol for 30 min; and (e) avidin-biotinylated horseradish peroxidase complex (Vector 
Laboratories, Inc.) for 30 min.  The reaction was  visualized with the chromagen 3,3'- 
diaminobenzidine tetrahydrochloride, 0.5  mg/ml,  in  PBS containing 0.01%  hydrogen 
peroxide, for 5 min. Between each of these steps the slides were washed in PBS for 10- 
20 min. After the label was developed the slides were washed in PBS, dehydrated through 
70  and  95%  ethanol,  and  stored  at  room  temperature  before processing for in  situ 
hybridization. 
In Situ  Hybridization.  This technique was  carried out as previously described (14). 
Cloned DNA of visna virus and cytomegalovirus (CMV) were separated from the pBR322 1972  la  EXPRESSION  IN  VISNA  LESIONS 
and used in this study. In brief, cloned DNA of visna virus was cleaved from the pBR322 
with the restriction endonuclease Sst I, and the 9.1  kilobase (kb) visna virus fragment was 
separated by electrophoresis in an agarose gel. The DNA of both viruses was radiolabeled 
by  nick  translation  (15)  using  3~S-dATP and  35S-dCTP  (Amersham  Corp.,  Arlington 
Heights,  IL). The labeled  probe was sized by alkaline-agarose electrophoresis and frag- 
ments measuring an average of 70 basepairs were used as previously described (16). The 
specific activities of the probes were >5 x  108 cpm/~g. 
The radiolabeled  DNA probes were applied to the tissue sections or cytocentrifuged 
preparations at a concentration of 0.2 #g/#l on slides pretreated with 0.2 N  hydrochloric 
acid  for  20  min,  heat  (70°C  for  30  min),  proteinase  K  (1-5  ug/ml)  for  15  rain,  and 
acetylation for 10 min. Slides were incubated with the probes for 50 h at room temperature 
and, after extensive washing, were autoradiographed for 2-10 d. The presence of viral 
RNA was indicated by silver grains over cells. To control for the specificity of the visna 
probe the latter was applied to normal uninfected tissue and cultures, and the CMV probe 
was used on visna-infected material. 
In combined immunocytochemistry and in situ hybridization experiments the specimens 
were first stained immunocytochemically with specific antibodies and then processed for 
in situ hybridization (14). Since the in situ hybridization signal is reduced after immuno- 
cytochemical staining, control slides processed for in situ hybridization alone were always 
included in this combined procedure. 
Spleen and Lymph Node Cultures.  Normal spleen and lymph node tissues were obtained 
from an adult sheep. Cells were teased from both tissues in petri dishes containing Ca++/ 
Mg++-free Hanks' salt solution, passed through a metal screen, and layered and centrifuged 
through a Ficoll-Hypaque gradient (2.4 parts of 9% Ficoll [Sigma Chemical Co., St. Louis, 
MO] to  1 part  of 33.9%  Hypaque [Winthrop  Laboratories,  Sterling  Drugs,  Inc.,  New 
York]). The cells were then resuspended in Dulbecco's modified Eagle's medium (DME) 
containing 5% lamb serum at a concentration of 5 x  106/ml, and 10 ml of the suspension 
cultures were added to Teflon bottles. These were incubated at 37°C in 5% COJair. 
Preparation of LV-IFN.  LV-IFN was prepared  as described  (7).  Briefly, macrophage 
cultures were derived in tissue culture dishes by seeding suspensions of peripheral blood 
mononuclear cells (PBM) obtained  from a  normal goat in  DME plus  20%  heated  lamb 
serum.  The cultures were inoculated with a  strain of sheep-goat lentivirus (in this case, 
caprine arthritis encephalitis virus) at a multiplicity of infection (moi) of 2 and incubated 
for 3 d. The infected cultures were then rinsed and inoculated with fresh PBM, obtained 
from the same donor, in serum-free DME. The supernatant fluid was harvested 2 d later, 
clarified by centrifugation at I 0,000 g for 15 min, heated at 56 °C for 30 min to inactivate 
the virus, and stored at -70°C. This fluid had an IFN titer of 1:320 when tested in the 
sheep macrophage-vesicular stomatitis virus assay system. 
Transformed Macrophages (TrMO).  A  cell line of alveolar macrophages from an unin- 
fected sheep  was prepared  by immortalizing cultures  of the  macrophages,  obtained by 
bronchoalveolar lavage,  with  SV40 (11).  The cells are  trypsin dissociable and  maintain 
macrophage functions. They were cultivated in DME containing 20% lamb serum, either 
as suspension cultures in Teflon bottles or as monolayer cultures in tissue culture dishes. 
la Induction Experiments.  In these experiments,  spleen and lymph node cell cultures 
in Teflon bottles received four different treatments.  Two of the spleen and lymph node 
cultures were treated  with LV-IFN for 24 h, after which VMA-5 virus was added at an 
moi of 1 to one of these; LV-IFN was maintained  in the media of both. The two other 
cultures  were either left untreated  or received virus alone without LV-IFN. Cells were 
harvested  at  various times  after  the  addition  of virus and  then  centrifuged  onto glass 
slides for immunocytochemistry. The cytospun cells were reacted with the anti-sheep Ia 
monoclonal antibody and then examined for stained Ia antigen.  In similar experiments, 
monolayers of TrMO  cultures  (see  above) were treated  with  VMA-5 virus alone,  IFN 
alone, or VMA-5 virus plus LV-IFN, or were left as untreated controls. LV-IFN was left 
in the culture media during a subsequent 24-h exposure to virus, immediately after which 
all cultures were processed and examined for Ia expression. We also studied the dynamics 
of Ia induction in TrMO cultures.  In these experiments,  cultures were exposed to LV- KENNEDY  ET  AL.  1973 
IFN for 6, 24, and 48 h and then examined for la expression at intervals of 0-72 h after 
the end of LV-IFN treatment. 
Effect of LV-IFN on Replication of Virus in Macrophage Cultures.  TrMO were seeded in 
tissue  culture  dishes  in  DME  plus  20%  lamb  serum  and,  at  confluence,  some  of the 
cultures  were treated  with  LV-IFN (1:10 dilution  of stock LV-IFN). On the  next day, 
treated and untreated cultures were inoculated with virus at an moi of 2 and incubated 
for 2  h  at  37°C.  Inocula were then  removed and replaced with  maintenance  medium. 
LV-IFN was  maintained  in  the  treated  cultures.  Supernatant  fluids  from both  sets  of 
cultures were harvested daily and assayed for infectivity in cultures of synovial membrane 
cells, as previously described (17). 
Results 
Viral RNA Expression  in Macrophages  in Different  Tissues.  To  investigate  the 
pathogenesis of the lymphoproliferative response in visna lesions, we first defined 
the tissues and cell  populations  that supported  viral  replication.  Viral  RNA  was 
detected  using in  situ  hybridization,  and,  in  double-labeling  experiments  using 
combined  in  situ  hybridization  and  immunocytochemistry,  it  was  possible  to 
localize  viral  RNA  in  macrophages  identified  with  the  antimacrophage  serum 
(6). 
Viral  RNA  was detected  in the lung, spleen,  and lymph nodes but not in the 
liver or brain.  Large numbers of macrophages containing many copies (100-500 
copies per cell) of viral RNA were detected in spleen and mediastinal and cervical 
lymph nodes;  much smaller numbers of infected cells were found in the mesen- 
teric  lymph node.  The  distribution  of virus-infected  macrophages  was as previ- 
ously described  (6) in  that  they were  found prominently  in the  marginal  zones 
surrounding the uninfected germinal centers (see Fig. 3). Large numbers of cells 
containing  viral  RNA  were  also  detected  in  the  lung  in  the  interstitial  spaces 
between  alveoli and  within  areas of peribronchial  inflammation.  We confirmed 
that  viral  infection  was  restricted  to  macrophages,  as  reported  previously  (6), 
and that these are found in the lung, mediastinal  and cervical lymph nodes, and 
spleen,  but  not  in  the  brain  (Table  I).  In  infected  tissues  only  a  very  small 
TABLE  I 
Percent of Viral RNA-containing Cells Identified  as Macrophages or la  + 
Cells in Different Tissues 
Viral RNA+/Mac  -  Viral RNA÷/Ia  + 
Tissue  rophage  + cells  cells 
% 
Lung  28.2*  33 
Mediastinal lymph node  88  7.7 
Spleen  85  5.6 
Brain  0  0 
Sections of tissues were stained with either antimacrophage or anti-Ia antibodies 
and then  treated  with  radiolabeled  viral  nucleic  acid  probe.  200 cells were 
counted on each slide and the percent of cells that both contained viral RNA 
and were labeled with the appropriate antibody was determined. The macro- 
phage data was obtained from Gendelman et al. (6); their figures  were con- 
firmed in this study. 
* The  72%  of cells that  were  not  labeled  with  the  antimacrophage  serum 
morphologically  resembled  pulmonary macrophages (6). 1974  la  EXPRESSION  IN  VISNA  LESIONS 
percentage  (~1%)  of the  total  number  of immunocytochemically identified 
macrophages contain viral RNA (6). Sections of infected tissues treated with the 
CMV probe and uninfected tissues treated with the visna probe did not show 
hybridization. 
Correlation Between Viral Replication and the Inflammatory Response.  The above 
data reiterated our previous observations (6) that viral replication is associated 
almost exclusively with infection in  selected macrophage populations.  Having 
established  this  pattern  of infection we  next  asked  whether  viral  replication 
occurred  only  in  tissues  containing  inflammatory lesions.  The  lymph  nodes 
showing the  greatest  lymphoproliferative response  were  the  mediastinal and 
cervical lymph nodes, which drain the lung and the brain, respectively. Both of 
these  nodes  showed  gross  hypertrophy  (10-15  times  normal  size)  and  also 
contained very large amounts of viral  RNA in  macrophages. By contrast, the 
mesenteric lymph node was not hyperplastic, did not show a lymphoproliferative 
response, and contained very few infected cells. The spleen showed a considerable 
inflammatory response and also contained many infected cells.  The liver con- 
tained neither viral RNA nor inflammatory lesions. The two target organs, the 
lung and the brain, both had inflammatory lesions consisting of a mononuclear 
cell infiltrate. However, the lung contained many infected macrophages whereas 
we did not detect viral  RNA in the brains of these animals at this point after 
virus inoculation. Thus, with the exception of the brain, viral RNA was confined 
to macrophages only in tissues that developed inflammatory lesions. 
Increased  Ia Antigen  Expression  in  Infected  Tissues.  The above  observations 
indicate  that  the  specific  infection  in  populations  of macrophages  was  one 
determinant of the lymphoproliferative response. We then asked how this semi- 
permissive infection, confined to macrophages, could cause lymphoproliferation. 
One way to reconcile these observations was the possibility of interference with 
normal immunological functions of the macrophages. Using antibodies to sheep 
Ia antigen, we examined tissue sections to determine whether there was increased 
expression of this antigen in macrophages. 
Ia antigens were detected in all tissues except liver.  Very few Ia  + cells  were 
seen in the brain, and only an occasional Ia  + cell was detected in the inflammatory 
lesions. Such cells  were extremely rare despite the presence of a  very marked 
inflammatory reaction in the brain. In the lung, a large number of Ia  + cells were 
seen  in  the mononuclear inflammatory cells  accumulating around bronchi, as 
well as in the interstitial spaces in the lung where macrophages had begun to 
accumulate (Fig. 1). The greatest amount of Ia immunoreactivity, as assessed by 
the size  of the areas of tissue sections stained and by the intensity of staining, 
was in the spleen and mediastinai and cervical lymph nodes, while a much smaller 
amount of staining was seen in the mesenteric lymph node and the normal lymph 
node and spleen controls. Ia antigen staining always showed the same pattern in 
lymph node and  spleen,  irrespective  of the  amount of staining,  and  intense 
staining of large cells  was noted in a  circular distribution around the germinal 
centers (Fig. 1). Fewer Ia  + cells were distributed throughout the sinusoidal areas 
of the spleen and lymph nodes. The distribution of Ia staining in the marginal 
areas  outside the germinal centers  very closely resembled  that seen  with  the 
antimacrophage  serum.  At  higher  magnification these  were  large  cells  with FIGURES 1-4.  Visna virus-la-macrophage  interactions: All  tissues (Figs.  1-3)  were  fixed  in 
PLPG and embedded in paraffin before immunocytochemical staining and]or in situ hybridi- 
zation. All sections or cultures were counterstained with hematoxylin. (1) The distribution of 
Ia antigens, after labeling with monoclonal antibody to sheep la antigen, in sections of visna- 
infected spleen (a) (original magnification, ×  300) and lung (b) (× 250).  (a) ia antigens are 
seen within and surrounding a follicle. (b) A lesser degree of la antigen staining is seen within 
an area of interstitial mononuclear cell infiltration (arrow). (2) Viral RNA in infected macro- 
phages that have also  been  labeled with  monoclonal anti-sheep Ia antibody, in sections of 
mediastinal lymph node (a) (×  500) and lung (b) (×  312).  (a) A  number of unstained cells 
contain viral RNA and one la  ÷ cell (arrow) also contains viral RNA. (b) Several cells express 
both  la  antigens and  viral  RNA.  (3)  A  section  of spleen  with  cells containing viral  RNA 
distributed in a  circular pattern around a  follicle but not within the germinal center (×'70). 
(4) Cultures of TrMO show labeling with anti-sheep Ia antibody after exposure to LV-IFN 
(× 400).  Note that three cells in the field show la labeling. 
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extensive cytoplasm, resembling macrophages, not lymphocytes. Most of the Ia  + 
cells  in the perigerminal center areas,  therefore, were almost certainly macro- 
phages. 
These  observations clearly show  that  there  was  a  persistent  and  increased 
expression of Ia antigens in the inflammatory lesions in tissues containing viral 
RNA, and that there was a correlation between the amounts of viral RNA and 
Ia antigen expressed by infected tissues. 
Double-Labeling  Experiments  to Identify  Ia  ÷ Cells  Containing  Viral RNA.  We 
next asked whether the Ia  + cells themselves were infected with virus. We used 
the combined in situ hybridization and immunocytochemical procedure to de- 
termine  the  proportion  of  Ia  +  cells  containing  viral  RNA.  The  results  are 
summarized in Table I, which also compares the numbers of viral RNA-positive/ 
macrophage-positive cells with those of the RNA+/Ia  ÷ cells. Neither viral RNA+/ 
Ia  + cells nor infected macrophages were detected in the brain. However, RNA+/ 
Ia  + cells were detected in the reactive lymphoid tissues, and larger numbers were 
present in the lung. One-third of the cells  containing viral  RNA expressed Ia 
antigen in the lung (Fig. 2) and these were located in both the inflammatory cell 
exudates and the pulmonary interstitial areas. 
By contrast, a  smaller proportion  (5.6-7.7%)  of virally infected spleen and 
lymph node cells were Ia  + (Fig. 2); these were located in a circular distribution 
surrounding, but never within, the germinal centers.  Since viral replication is 
virtually restricted to macrophages, it is clear that the RNA+/Ia  + cells represented 
a  small subpopulation of Ia  + macrophages that were infected with virus.  This 
population  is  estimated  to  be  ~0.07%  of the  total  number  of macrophages 
identified in tissue sections stained with the antimacrophage serum. 
Induction of la Antigens in Spleen and Lymph Node In Vitro by LV-IFNI  Having 
demonstrated increased and persistent expression of Ia antigens in the inflam- 
matory lesions,  and  virus  infection  in  some of these  cells,  we  addressed  the 
question of how these Ia antigens might be induced in vivo. We designed in vitro 
experiments to test two possible mechanisms: a direct infection of macrophages 
or induction of Ia by LV-IFN. 
Since  the  spleen  and  lymph  nodes  contained  the  greatest  amounts  of  Ia 
antigens, cultures of normal sheep spleen and lymph nodes were treated with 
virus and/or LV-IFN and examined immunocytochemically to detect increases 
in their Ia expression.  At day  1  in  spleen  cultures exposed to  LV-IFN alone 
(Tables  II  and  III),  there  was  a  70%  increase  in  the  percentage  of Ia  + cells 
compared with untreated control cultures and cultures treated with virus alone. 
Treatment of cultures with LV-IFN plus virus also caused a marked increase in 
Ia antigen expression, and the increases were still  present at day 5.  There was 
no noticeable difference in expression of Ia in cells in infected cultures compared 
with uninfected control cultures. The results in lymph node cells showed a very 
similar increase in Ia expression with LV-IFN. The intensity of the surface Ia 
staining was  also increased in cultures showing an  increase in the overall per- 
centage of Ia  + cells.  It was clear that Ia antigens could be increased by LV-IFN 
but not by virus infection alone. 
la Induction by LV-IFN in TrMO Cultures.  Although we demonstrated a clear 
increase in la antigen expression in spleen and lymph node cells by LV-IFN, we KENNEDY  ET  AL.  1977 
TABLE  II 
la Expression in Splenocytes After Exposure to Virus and~or LV-IFN 
Percent of cells expressing la antigen in cultures of: 
Time after vi- 
rus exposure*  Splenocytes  Splenocytes +  Splenocytes +  Splenocytes + 
(control)  LV-IFN  virus  virus +  LV-IFN 
d  % 
1  27  46  28.5  55.5 
5  22  58.5  20.5  48 
Two of the splenocyte cultures were treated with IFN for 24 h and then visna virus 
was added to one while maintaining 1FN in the media of both. Other cultures were 
only exposed to virus (moi of 1); control cells received neither virus nor IFN. 200 
cells per slide were counted in duplicate experiments and the percent of cells labeling 
with anti-Ia antibody was determined. 
* The percent of control cells expressing la was 22% immediately after cell dissociation 
at day 0. 
TABLE  III 
Ia Expression in Lymph Node Cells After Exposure to Virus and~or LV-IFN 
Percent of cells expressing Ia antigen in cultures of: 
Time after vi- 
rus exposure*  Lymph node  Lymph node +  Lymph node +  Lymph node + 
(control)  LV-IFN  virus  virus +  LV-IFN 
d  % 
1  26.5  59  29  50.5 
3  25.5  49.5  25.5  45 
6  26  58  18  40 
Dissociated lymph nodes were treated as described in text and in legend to Table II. 
Results were determined as described in legend to Table lI. 
* The percent of control cells expressing la was 26% immediately after dissociation at 
day 0. 
could not  identify with  certainty  the  cell  type in  which  the  antigen  had  been 
induced because of the pluripotentiality of spleen and lymph node cells to express 
Ia. To determine whether macrophages would express Ia antigens after infection 
or after treatment with LV-IFN, we prepared four cultures of TrMO in Teflon 
bottles and  made  the  following inoculations:  (a)  no treatment;  (b) virus at an 
moi  of 3;  (c)  LV-IFN  (1:10  with  stock);  (d)  virus  plus  LV-IFN  at  the  same 
concentrations used in b and c. There was no constitutive expression of Ia antigen 
in the macrophages, and infection of the macrophages with virus alone did not 
result  in  Ia  expression.  However, cultures  that  had  received  LV-IFN with  or 
without infectious virus showed high levels of Ia expression, with  17.5% of the 
total cells expressing Ia antigens.  Since these cultures are heterogeneous (11) it 
was  not  surprising  that  only  a  proportion  of the  macrophages  expressed  Ia 
antigens after LV-IFN treatment. 
Dynamic  Studies  of la  Induction  by  LV-IFN  in  TrMO  Cultures.  The  above 
experiments showed that expression of Ia antigen by the TrMO was contingent 
upon the  presence of LV-IFN.  To determine  the dynamics of Ia  induction  in 
these cells, TrMO cultures were exposed to LV-IFN for varying periods at 37 °C 
and then examined for Ia expression 0-72 h after removal of the LV-IFN. After 
each treatment period, the cells were removed, washed by centrifugation, resus- 1978  Ia  EXPRESSION  IN  VISNA  LESIONS 
TABLE  IV 
Dynamic Studies of L V-IFN-induced Ia Antigen Expression in Transformed 
Macrophage Cultures 
Percent of cells expressing la antigens after LV-IFN treatment 
Duration of LV-  Time after end of treatment  IFN exposure 
0 h  6  h  24 h  48 h  72 h 
6h  0  0  5  2  <1 
24 h  9  7.5  4.5  3  <i 
48 h  11  5  4  1  <1 
14 d  " 5  ND*  ND  ND  ND 
Cultures of TrMO  in Teflon bottles were exposed to LV-IFN for 6, 24, and 48 h and 
then examined for la expression at intervals after the end of the treatment.  Results 
were  determined  as  described  in  legend  to  Table  II.  Untreated  control  cultures 
remained negative for Ia expression throughout the experiment. 
* Not done. 
pended  in  fresh  medium,  and  reincubated  at  37°C.  The  results  (Table  IV) 
showed: (a) Ia antigens did not appear until 6-24 h after LV-IFN exposure; (b) 
irrespective of the  duration  of LV-IFN  treatment,  Ia  antigens  were  rapidly 
depleted in culture, with <1% of the total cells being Ia  + after 72 h; (c) increasing 
the  time  of exposure  to  LV-IFN  slightly  increased  the  percentage  of  cells 
expressing Ia; and (d) maintaining LV-IFN  in  the cultures for longer periods 
increased the total duration of Ia expression. When LV-IFN was maintained in 
the cultures for 2 wk, 5% of the total cells were found to be Ia  ÷, indicating that 
Ia expression required the continuous presence of LV-IFN in the medium. Since 
the TrMO population  was heterogeneous and dividing, it is possible  that this 
continuous Ia expression represented transient asynchronous expression of Ia by 
different cells. 
Effects of LV-IFN on Lentivirus Replication in Macrophages.  Having shown that 
LV-IFN could induce Ia antigen expression in macrophage cultures, we asked 
whether the IFN would also cause reduction in virus replication in the macro- 
phages (Fig.  5).  Infected cultures treated with  LV-IFN  produced ~l,000-fold 
less infectious virus than untreated controls. 
Discussion 
We  have  shown  in  this  report  that  the  lymphoproliferative inflammatory 
response caused by visna virus in sheep was associated with a  persistently high 
level of transcription of the viral genome in macrophages, accompanied by an 
intense level of expression of Ia antigen in infected and uninfected macrophage- 
like cells.  In a  previous study (6)  we showed that replication of this virus was 
confined to cells of the macrophage lineage, with no involvement of lymphocytes. 
The mechanism of lymphoproliferation represented a paradox. Our finding that 
these lentiviruses induce an IFN during the interaction of infected macrophages 
and lymphocytes and that the IFN in  turn caused expression of Ia antigen in 
infected and uninfected macrophages, provides a fresh perspective for evaluating 
the pathogenesis of the persistent virus-induced inflammation. 
The combined immunocytochemical and in situ hybridization procedure pro- KENNEDY  ET  AL.  1979 
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FZGURE 5.  Infectivity titers in TrMO  cultures inoculated with VMA-5 at an moi of 2  and 
maintained with (---) and without (--) LV-IFN. 
vided an excellent means to identify viral RNA in cells expressing  Ia antigens. 
Since  viral  RNA  was  found  only  in  macrophages,  the  small  number  of cells 
containing  viral  RNA  and  Ia  antigen  must  have  been  infected  macrophages 
expressing  Ia  antigen.  By implication,  if the  same  cell that  is  presenting  viral 
antigen  to helper T  cells is also infected with virus, a  potentially aberrant  host 
immune  response  could  result,  leading  possibly  to  lymphoproliferation  and 
failure to clear the infection. Infection of Ia  ÷ macrophages has also been reported 
(18) in mice infected with lactic dehydrogenase virus, and similar abnormal host 
responses  have  also been  implicated  in  this  infection.  Large  numbers  of such 
infected  Ia  ÷ cells may not  be  required  to  maintain  this  aberrant  response.  A 
greater  percentage  of RNA+/Ia  +  cells  was  detected  in  the  lung  than  in  the 
mediastinal  lymph node and  spleen.  Although  the reasons for this discrepancy 
are not clear, it almost certainly relates to the different status of the two tissues, 
in  that  the  lung  is  a  primary  target  organ  for  the  disease whereas  the  other 
tissues  are  reactive.  Virus  replication,  however,  remained  restricted  in  all  of 
these organs. 
The amounts of Ia antigen and viral RNA expression were closely correlated 
in the lung,  lymph nodes, and spleen, which were tissues with ongoing inflam- 
matory lesions. Our in vitro data showed that Ia was induced in macrophages by 
LV-IFN but not by virus infection alone, and that  Ia expression diminished in 
the absence of LV-IFN in the  medium.  Therefore,  persistent expression of Ia 
antigen required the continuous presence of IFN. Extrapolation of these data to 
events in the animal suggests that virus infection alone is not sufficient to induce 
Ia expression in macrophages. We speculate that IFN must be induced locally to 
cause  expression  of  this  antigen.  This  in  turn  could  generate  the  ongoing 
inflammatory induction of T  lymphocyte populations. Although LV-IFN has not 
been isolated from infected tissues (7), both infected macrophages and lympho- 
cytes, which are required for its production  (7), are present within  the inflam- 
matory lesion. 
It  was  clear  from  our  studies  that  viral  RNA  expression  in  macrophages 1980  la  EXPRESSION  IN  V1SNA  LESIONS 
correlates  with  both  inflammation  and  high  expression  levels  of Ia  antigens. 
However, virus-cell reactions in the brain were different from those in the lung 
and lymph nodes. Encephalitis at 2 and 12 wk after intracranial  virus inoculation 
was associated with neither viral RNA nor Ia antigen expression. Other investi- 
gators  (19) have  examined  visna  virus expression  in  brain  and  detected small 
amounts of viral  RNA 6  wk after inoculation.  Differences in  virus strains  and 
breeds of sheep may account for these discrepancies.  In our study it is possible 
that  the paucity of viral  RNA in  CNS cells may reflect a  greater  resistance  of 
these cells to infection and/or a  unique  response of CNS tissues to fixation or 
other laboratory procedures that may have occluded access of the probe to the 
RNA. These possibilities are being examined in current experiments.  Previous 
studies have shown that the visna brain lesions are immunopathologic, since they 
may be prevented by immunosuppression  (20) and their induction  is associated 
with a virus-specific cellular immune response (21). We have also shown (5) that 
cell-free virus can be isolated from brain tissue homogenates soon after inocula- 
tion but not at 3 mo and that lesions proceed to scarification, instead of chronic 
inflammation  as  found  in  the  lung  (5),  We  interpret  the  inflammatory  brain 
lesions that lacked both Ia and virus RNA at and beyond 2 wk postinoculation 
as being  reparative  rather  than  chronic,  in  keeping  with an  episodic  "hit-and- 
run"  pathogenesis.  Persistence or lack of expression of Ia and  viral  RNA may 
thus  help  determine  whether  lesions  become chronic  and  indolent,  as  in  the 
lung, or episodic, as in the brain. 
The ability of LV-IFN to inhibit virus replication in TrMO may be an in vitro 
correlate of virus replication in vivo and may be implicated in the mechanism of 
restricted  virus  replication  in  tissue  macrophages.  IFN-mediated  restriction  of 
replication  of retroviruses occurs at a  late stage of the virus life cycle, between 
assembly and maturation of the infectious virion (22).  Whether this also applies 
to the replication of the lentiviruses is not known. The precise stage of the virus 
life cycle in TrMO blocked by LV-IFN has not been identified,  but our results 
may provide a model system for further dissection of the semi-abortive replicative 
cycle of the virus in tissue macrophages. 
Although  LV-IFN  has  not  been  identified  directly  in  tissue  extracts,  the 
manner of restriction of virus replication, the persistence of Ia antigen expression, 
and the local presence of the cells required for virus production provide strong 
circumstantial  evidence for a  role of LV-IFN in vivo. Our studies suggest that 
LV-IFN induced in vivo during replication of lentiviruses may have both bene- 
ficial  and  deleterious  effects on  the  host.  Whereas  LV-IFN may restrict  virus 
replication  and  thus  slow  the  course  of the  infection,  it  may  also  induce  Ia 
antigens  in  infected macrophage target cells and potentiate  immunopathologic 
disease. Such a pathogenesis may apply to the lymphadenopathy seen in humans 
with acquired immune deficiency syndrome (AIDS), in which the replication of 
lentivirus HTLV-III is minimal,  lymphoproliferation is high,  and IFN levels in 
serum are clearly detectable (23-25). 
Summary 
In  this  study  we  investigated  the  pathogenesis  of the  lymphoproliferative 
response in the chronic-active visna maedi virus-induced  inflammatory lesions. KENNEDY ET  AL.  198I 
Viral RNA expression was confined to macrophages, but only in tissues showing 
inflammatory lesions. A  persistent and high level of Ia antigen expression was 
seen in macrophage-like cells in the inflammatory lesions, and the amounts of 
viral RNA and Ia expression were closely correlated. A small subpopulation of 
macrophages contained both viral RNA and Ia antigen, and these were found in 
greatest  number  in  the  lung.  In  vitro  experiments  showed  that  a  ientivirus- 
induced interferon (LV-IFN) could induce Ia antigens in normal sheep spleen 
and lymph node cells as well as in a transformed sheep macrophage cell line. Ia 
antigen expression in macrophages was transient in the absence of a continuing 
IFN stimulus and persisted for at least 2 wk in the presence of LV-IFN. LV-IFN 
also  restricted  viral  replication  in  macrophages.  It  is  suggested that  LV-IFN 
induced by the inflammatory cells in visna-maedi lesions may induce Ia antigen 
expression in macrophages, thereby indirectly causing the lymphoproliferative 
response and restricted virus replication. 
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